<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Legal Sleuth® ** Case Watch℠ - FDA Archives &#8212; Gooch Law Firm</title>
	<atom:link href="https://legalsleuth.com/tag/fda/feed/" rel="self" type="application/rss+xml" />
	<link>https://legalsleuth.com/tag/fda/</link>
	<description>The Source for All Things Legal ℠ - Information, Resources and Services</description>
	<lastBuildDate>Tue, 28 Apr 2015 21:44:22 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	

<image>
	<url>https://legalsleuth.com/wp-content/uploads/2016/02/icon-34-150x150.png</url>
	<title>Legal Sleuth® ** Case Watch℠ - FDA Archives &#8212; Gooch Law Firm</title>
	<link>https://legalsleuth.com/tag/fda/</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Drug Labels</title>
		<link>https://legalsleuth.com/drug-labels/</link>
		
		<dc:creator><![CDATA[Legal Sleuth®]]></dc:creator>
		<pubDate>Sat, 27 Sep 2014 18:07:23 +0000</pubDate>
				<category><![CDATA[Prescription Drug]]></category>
		<category><![CDATA[drug labels]]></category>
		<category><![CDATA[drugs]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[prescription drugs]]></category>
		<guid isPermaLink="false">http://legalsleuth.com/?p=5413</guid>

					<description><![CDATA[<p>Recently, the Food and Drug Administration proposed amending its regulations in connection with drug labels to revise and clarify procedures for an approved drug or biological product to change the product labeling to reflect certain types of newly acquired information in advance of FDA’s review of the change.  The basic rule would allow holders of [&#8230;]</p>
<p>The post <a href="https://legalsleuth.com/drug-labels/">Drug Labels</a> appeared first on <a href="https://legalsleuth.com">Legal Sleuth®</a>.</p>
]]></description>
		
		
		
			</item>
		<item>
		<title>Nuvaring Label Change</title>
		<link>https://legalsleuth.com/nuvaring-label-change/</link>
		
		<dc:creator><![CDATA[Legal Sleuth®]]></dc:creator>
		<pubDate>Tue, 11 Mar 2014 17:59:58 +0000</pubDate>
				<category><![CDATA[Medical Devices]]></category>
		<category><![CDATA[blood clots]]></category>
		<category><![CDATA[deep vein thrombosis]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[heart attacks]]></category>
		<category><![CDATA[label change]]></category>
		<category><![CDATA[nuvaring]]></category>
		<category><![CDATA[pulmonary embolisms]]></category>
		<category><![CDATA[strokes]]></category>
		<guid isPermaLink="false">http://legalsleuth.com/?p=5439</guid>

					<description><![CDATA[<p>Recently, the FDA issued a nuvaring label change.  Apparently, a nuvaring label change was approved by the FDA Center for Drug Evaluation and Research (CDER) on October 2013.  The nuvaring label change was related to Thromboembolic Disorders and Other Vascular Problems.  In particular, the nuvaring label change stated the following: Stop NuvaRing use if an [&#8230;]</p>
<p>The post <a href="https://legalsleuth.com/nuvaring-label-change/">Nuvaring Label Change</a> appeared first on <a href="https://legalsleuth.com">Legal Sleuth®</a>.</p>
]]></description>
		
		
		
			</item>
		<item>
		<title>FDA, Topamax, Cleft Lip &#038; Birth Defect</title>
		<link>https://legalsleuth.com/fda-topamax-cleft-lip-birth-defect/</link>
		
		<dc:creator><![CDATA[Legal Sleuth®]]></dc:creator>
		<pubDate>Tue, 18 Feb 2014 02:04:28 +0000</pubDate>
				<category><![CDATA[Birth Defect]]></category>
		<category><![CDATA[Personal Injury]]></category>
		<category><![CDATA[Prescription Drug]]></category>
		<category><![CDATA[birth defect]]></category>
		<category><![CDATA[cleft lip]]></category>
		<category><![CDATA[cleft palate]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[topamax]]></category>
		<guid isPermaLink="false">http://legalsleuth.com/?p=4802</guid>

					<description><![CDATA[<p>FDA, Topamax, Cleft Lip &#38; Birth Defect: Back in March 2011, the FDA review of topamax was a startling revelation to many of its users.  The FDA review of topamax published in 2011 concerning the use of TOPAMAX® during pregnancy stated that if you take Topamax during pregnancy, your baby has a higher risk for [&#8230;]</p>
<p>The post <a href="https://legalsleuth.com/fda-topamax-cleft-lip-birth-defect/">FDA, Topamax, Cleft Lip &#038; Birth Defect</a> appeared first on <a href="https://legalsleuth.com">Legal Sleuth®</a>.</p>
]]></description>
		
		
		
			</item>
	</channel>
</rss>
